INTRODUCTION
Glycation of proteins by glucose and other saccharide derivatives leads to the formation of fructosamines [1, 2] and advanced glycation endproducts (AGEs) [3, 4] . Formation of AGEs has been linked to the development of cataract [5] , diabetic complications [6] , uraemia [7] , Alzheimer's disease [8] and other disorders [3] . The association of AGEs with disease is thought to reflect AGE-dependent changes in protein structure and function. These are (i) changes in protein structure arising from loss of lysyl, arginyl or N-terminal ionization, introduction of ionized AGE structures and changes in local hydrophobicity [9] , (ii) resistance to proteolysis by AGE-mediated cross-linking [10] and (iii) binding to cell-surface receptors (AGE receptors) and other proteins (lysozyme, lactoferrin) specifically with associated cell activation or impairment of protein function (reviewed in [11] ).
Abbreviations used : AGE, advanced glycation endproduct ; HSA, human serum albumin ; AGE-HSA, HSA modified highly by glucose-derived glycation adducts ; AGE min -HSA, HSA modified minimally by glucose-derived glycation adducts ; AQC, 6-aminoquinolyl-N-hydroxysuccinimidylcarbamate ; CEL, N ε -(1-carboxyethyl)lysine ; CML, N ε -carboxymethyl-lysine ; 3DG-H1, N δ -[5-(2,3,4-trihydroxybutyl)-5-hydro-4-imidazolon-2-yl]ornithine ; DOLD, 3-deoxyglucosone-derived lysine dimer, 1,3-di(N ε -lysino)-4-(2,3,4-trihydroxybutyl)-imidazolium salt ; G-H1, N δ -(5-hydro-4-imidazolon-2yl)ornithine ; G-H2, 2-amino-5-(2-amino-5-hydro-4-imidazolon-1-yl)pentanoic acid ; GOLD, glyoxal-derived lysine dimer, 1,3-di(N ε -lysino)imidazolium salt ; MALDI-MS, matrix-assisted laser-desorption ionization MS ; MG-H1, N δ -(5-hydro-5-methyl-4-imidazolon-2-yl)-ornithine ; MG-H2, 2-amino-5-(2amino-5-hydro-5-methyl-4-imidazolon-1-yl)pentanoic acid ; MG-H3, 2-amino-5-(2-amino-4-hydro-4-methyl-5-imidazolon-1-yl)pentanoic acid ; MG-HSA, HSA modified highly by methylglyoxal-derived glycation adducts ; MG min -HSA, HSA modified minimally by methylglyoxal-derived glycation adducts ; MOLD, methylglyoxal-derived lysine dimer, 1,3-di(N ε -lysino)-4-methyl-imidazolium salt ; PR, human prothrombin ; MG min -PR, PR modified minimally by methylglyoxal-derived glycation adducts ; THP, N δ -(4-carboxy-4,6-dimethyl-5,6-dihydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)ornithine ; t-Boc, t-butyloxycarbonyl. 1 To whom correspondence should be addressed (e-mail thorp!essex.ac.uk).
without derivatization. Human serum albumin (HSA) glycated minimally by methylglyoxal in itro contained mainly MG-H1 with minor amounts of THP and argpyrimidine. Similar AGEs were found in prothrombin glycated minimally by methylglyoxal and in N α -t-butyloxycarbonyl-arginine incubated with methylglyoxal. HSA glycated highly by methylglyoxal contained mainly argpyrimidine, MG-H1 and THP, with minor amounts of CEL and MOLD. HSA glycated minimally by glucose in itro contained mainly fructosyl-lysine and CML, with minor amounts of THP, MG-H1, G-H1, 3DG-H1, argpyrimidine and DOLD. HSA glycated highly by glucose contained these AGEs and pyrraline, and very high amounts ($ 8 mol\mol of protein) of fructosyl-lysine. Most AGEs in albumin glycated minimally by methylglyoxal and glucose were identified. Significant proportions of arginine and lysine-derived AGEs in albumin modified highly by methylglyoxal, and lysine-derived AGEs in albumin modified highly by glucose, remain to be identified.
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To investigate these and other functional effects of glycation, model glycated proteins have been prepared in itro.
Proteins have been glycated in itro by glucose, methylglyoxal and other saccharide derivatives [12] [13] [14] . The extents of modification have been minimal (1-2 mol of glycating agent attached per mol of protein) to high (30-40 mol\mol of protein) [9, 15] . Proteins have also been prepared that contain specific AGEs, such as N ε -carboxymethyl-lysine (CML) and N ε -(1-carboxyethyl)lysine (CEL), with minimal to high extents of modification ; the N-carboxymethyl and N-carboxyethyl moieties were introduced into the protein chemically [16] [17] [18] . With glycation by saccharide derivatives, however, proteins contain two or more AGEs. AGEs are a group of arginine, lysine and N-terminal amino acid residue-derived molecules of diverse structure [3] . This structural diversity confers distinctive functional changes, typically multifunctional changes, on the glycated protein. To correlate functional activity of glycated proteins with AGE epitopes and concentration, a survey of AGE content of glycated proteins is required.
In this report, we describe the application of the 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate (AQC) chromatographic assay of AGEs, and assay of AGEs with intrinsic fluorescence, to the measurement of AGEs in human serum albumin (HSA) glycated to minimal and high extents by methylglyoxal and glucose.
MATERIALS AND METHODS

Materials
HSA (fatty acid-free), human prothrombin (PR), pepsin (from porcine stomach mucosa ; Sigma catalogue no. P6887), pronase E, prolidase, leucine aminopeptidase (type VI from porcine kidney) and N α -t-Boc-arginine (where t-Boc is t-butyloxycarbonyl) were purchased from Sigma. Methylglyoxal, AQC, N ε -(1-deoxy--fructos-1-yl)lysine (referred to as fructosyl-lysine) and AGEs were prepared as described in the accompanying article [17] .
Preparation of proteins glycated by methylglyoxal and glucose
HSA glycated minimally by methylglyoxal-derived glycation adducts (MG min -HSA) was prepared by incubation of methylglyoxal (500 µM) with HSA (6.6 mg\ml) in sodium phosphate buffer (100 mM, pH 7.4) at 37 mC for 24 h. A similar preparation of PR minimally modified by methylglyoxal-derived glycation adducts (MG min -PR) was made. Unmodified protein controls were incubated without methylglyoxal and processed similarly. HSA modified highly by methylglyoxal-derived glycation adducts (MG-HSA) was prepared by incubation of HSA (7.2 mg\ml) with methylglyoxal (100 mM) in 100 mM sodium phosphate buffer, at pH 7.4 and 37 mC, for 24 h. Unmodified protein controls were incubated without methylglyoxal and processed similarly.
HSA modified minimally by glucose-derived glycation adducts (AGE min -HSA) was prepared by incubation of HSA (50 mg\ml) with β--glucose (40 mM) in sodium phosphate buffer (150 mM, pH 7.4) at 37 mC for 5 weeks under aseptic conditions. Unmodified protein control was incubated without glucose and processed similarly. HSA modified highly by glucose-derived glycation adducts (AGE-HSA) was prepared by incubation of HSA (50 mg\ml) with β--glucose (1.67 M) in sodium phosphate buffer (100 mM, pH 7.4) at 37 mC for 60 days under aseptic conditions. Unmodified protein control was incubated without glucose and processed similarly.
After incubation, all proteins were dialysed against 30 mM ammonium formate, pH 7.8 and 4 mC, lyophilized to dryness and stored at k20 mC.
Model of the reaction of methylglyoxal with arginine residues in proteins
A model incubation of 500 µM methylglyoxal with 2.4 mM N αt-Boc-arginine in sodium phosphate buffer (100 mM, pH 7.4) at 37 mC for 24 h was performed, analogous to the methylglyoxal and arginine residue concentrations in the preparation of MG min -HSA. An aliquot of this incubation (200 µl) was acidified to pH 1 with 2.2 M HCl (20 µl) and stirred overnight at room temperature. Of this, 1 % (4.8 nmol of arginine residues) was derivatized with AQC and analysed as described for the protein AGE assay [17] . N α -t-Boc-arginine and N α -t-Boc-arginine-derived AGEs [N δ -(5-hydro-5-methyl-4-imidazolon-2-yl)-ornithine (MG-H1), N δ -(4-carboxy-4,6-dimethyl-5,6-dihydroxy-1,4,5,6tetrahydropyrimidin-2-yl)ornithine (THP), 2-amino-5-(2-amino-5-hydro-5-methyl-4-imidazolon-1-yl)pentanoic acid (MG-H2) and argpyrimidine] were used as calibration standards with identical acidic processing. The recoveries of these analytes were 55, 54, 54, 83 and 93 %. 2-Amino-5-(2-amino-4-hydro-4-methyl-5-imidazolon-1-yl)pentanoic acid (MG-H3) was not determined because of its instability during the chromatographic run.
Sample processing and assay of AGEs by the AQC and intrinsic fluorescence chromatographic methods
The protein concentration was determined by the Bradford method [19] . Protein samples were hydrolysed enzymically under nitrogen as described in [17] . The hydrolysate was then used in the assay of AGEs by the AQC and intrinsic fluorescence techniques. Aliquots of enzymic hydrolysate (50 µl, equivalent to 50 µg of protein) were derivatized by AQC and analysed by HPLC with fluorimetric detection. Argpyrimidine and pentosidine contents of the proteins were also determined without derivatization by HPLC with fluorimetric detection [17] . Only analyte concentrations higher than the statistical limit of detection are given.
RESULTS
Analysis of AGEs in HSA and PR modified minimally and highly by methylglyoxal
Analysis of AGEs by the AQC chromatographic method in unmodified HSA and PR gave evidence of low or undetectable levels of AGE analytes. A specimen chromatogram of the analysis of amino acids and glycation adducts in HSA is given in Figure  1 (a), with an expansion of the section between 75 and 95 min is given in Figure 2 (a). (Note that named analytes in the following description refer to AQC-analyte adducts.) Arginine eluted with threonine at $ 42 min ; a repeat run of the initial 90 min with a modified gradient was required to resolve arginine and threonine, eluting at 28 and 32 min, respectively. Proline eluted at 77 min and the internal standard, α-aminobutyric acid, eluted at 89 min. Lysine eluted at 173 min. At this high sensitivity and high sample loading, many small analyte peaks can be seen between amino acid and internal-standard peaks. These many trace amino acid derivatives necessitated the extraordinary long run time for resolution. Chromatographic peaks were assigned to the following analytes under investigation :
, MG-H1, THP, argpyrimidine and fructosyl-lysine (Tables 1-3 ). In HSA, there were generally low levels of MG-H1 and THP, although in one batch of HSA there was $ 0.5 mol of MG-H1\mol of HSA. Typically, however, there were higher levels of G-H1 and 3DG-H than all other AGEs (see below).
Analysis of the AGEs in MG min -HSA indicated the presence of MG-H1 as the predominant AGE with minor formation of THP and argpyrimidine (Table 1 and Figures 1b and 2b) . The two epimers of MG-H1 had retention times of $ 82 and 85 min, with the appearance of smaller peaks of the epimers of THP at $ 84 and 87 min. An unidentified interfering peak (retention time, 81 min) was generally found in the analysis of the proteins. This was incompletely resolved from AGE epimer MG-H1 A . Since there was racemization of epimers of MG-H1 (the chromatographic peak areas of AGE epimers MG-H1 A and MG-H1 B were not significantly different), the chromatographic peak for MG-H1 B was integrated for the quantification of MG-H1. Similarly, the second epimer peak of THP eluting at $ 87 min, THP B , was integrated for the quantification of THP in AGE protein analysis. The chromatographic peaks of MG-H1 epimers were clearly evident in the chromatogram. There was no detectable formation of CEL or MOLD [methylglyoxal-derived lysine dimer, 1,3-di(N ε -lysino)-4-methyl-imidazolium salt], nor glyoxal-derived AGEs, CML and GOLD [glyoxal-derived lysine dimer, 1,3-di(N ε -lysino)imidazolium salt]. There was no significant decrease of lysine residues but there was a decrease of $ 2 arginine residues\mol in the formation of MG min -HSA. This was accounted for mostly by the formation of MG-H1 and also the formation of THP and argpyrimidine. Similarly, the minimal modification of PR led to the formation of MG-H1, THP and argpyrimidine but there was no detectable CEL or MOLD. The formation of THP and argpyrimidine was more marked in MG min -PR than in MG min -HSA ( Table 2) .
The time course of formation of methylglyoxal-derived AGEs in MG min -HSA (500 µM methylglyoxal and 100 µM HSA incubated at pH 7.4 and 37 mC for 1 day) was studied. The effect of methylglyoxal-derived AGE stability on AGE content was also studied by extending the incubation over a further 3 weeks (Figure 3a ). MG-H1 formation occurred rapidly in the initial 6 h and attained a maximum value in the subsequent 18 h. Over the next 3 weeks, however, there was a further slow increase in MG-H1 concentration. THP was also formed in the initial 24 h of incubation and decreased thereafter. Argpyrimidine was formed only after 12 h of incubation and increased to a maximum after 24 h.
It was of interest to see if the same AGEs could be detected by incubation of methylglyoxal with N α -t-Boc-arginine at a concentration equivalent to that of arginine residues in 100 µM HSA. Therefore, 500 µM methylglyoxal was incubated with 2.4 mM N α -t-Boc-arginine under the same conditions used for the preparation of MG min -HSA ; the t-Boc group was removed by acid hydrolysis prior to AGE analysis. A time course of chromatograms indicating the formation of MG-H1 and THP is given in Figure 4 . There was also a small, constant amount of MG-H2 present in the N α -t-Boc-arginine throughout the incubation. The chromatograms shown were run immediately after AQC derivatization and also indicate the presence of MG-H3, although because this AQC adduct was unstable [17] its concentration was not deduced. Argpyrimidine was not detected. The time course of MG-H1 and THP formation over the 24 h incubation is shown in Figure 3 MG-HSA contained increased amounts of MG-H1 and there were also detectable levels of MOLD and CEL at retention times of 169 and 209 min. The most striking difference with the high modification of HSA by methylglyoxal, however, was the presence of high contents of THP epimers (retention times, 84 and 87 min) and argpyrimidine (retention time, 137 min ; Figures 1c  and 2c ). The decrease of arginine residues in MG-HSA was Table 1 ).
Argpyrimidine and pentosidine were assayed without derivatization by HPLC with fluorimetric detection. HSA had 6.08 mmol of argpyrimidine\mol of protein and 0.25 mmol of pentosidine\mol of protein, although this varied from batch to batch (the ranges were 2-10 mmol of argpyrimidine\mol of protein and 0.03-0.5 mmol of pentosidine\mol of protein). Glycation of HSA by methylglyoxal increased argpyrimidine content significantly (P 0.001) but not pentosidine content (P 0.05). In MG min -HSA and MG-HSA, there was 176p2 and 4322p1765 mmol\mol of protein, respectively (Figures 5a and  5b) . These estimates were in reasonable agreement with the argpyrimidine content determined by the AQC method ( Table  1) . Incubation of methylglyoxal (500 µM) with 100 µM HSA in the preparation of MG min -HSA for 3 weeks, instead of the usual 24 h, led to a small decrease in argpyrimidine content (127p37 versus 176p2 mmol\mol of protein respectively, n l 4) which was not significant (P 0.05).
HSA modified minimally and highly by glucose
Analysis of AGEs in HSA by the AQC chromatographic method gave evidence of low or undetectable levels of methylglyoxalderived AGE analytes (described above) and higher contents of G-H1 and 3DG-H1. A specimen complete chromatogram with fluorescence detection is given in Figure 6 , with an expansion of the chromatogram in the retention interval 70-120 min in Figure  7 . Analysis for G-H1 and 3DG-H1 (retention times $ 56 and 59 min, respectively) indicated relatively high contents of these analytes and highly variable amounts of G-H1 ( Figure  6a and Table 3 ). The marked variability of G-H1 content was due to differences in G-H1 content in commercial batches of HSA. This suggests that hydroimidazolones G-H1 and 3DG-H1 are major AGEs in purified proteins ; they were also present at similar levels in prothrombin.
AGE min -HSA contained increased levels of fructosyl-lysine and CML with smaller increases in hydroimidazolones G-H1, 3DG-H1 and MG-H1, argpyrimidine and DOLD [3-deoxyglucosone-derived lysine dimer, 1,3-di(N ε -lysino)-4-(2,3,4-trihydroxybutyl)-imidazolium salt], with respect to unmodified HSA (Figures 6b, 7b and 7e, and Table 3 ). Similar AGEs and also pyrraline were detected in the analysis of AGE-HSA ( Figures  6c, 7c and 7f, and Table 2 ). With the increasing extent of modification of HSA by glucose in AGE-HSA, the most marked changes in the analytes measured were (i) an increase in the fructosyl-lysine peak (retention time, $ 100 min), (ii) an increase in the CML peak ($ 116 min), (iii) the appearance of MG-H1 and THP epimer peaks in retention interval 80-84 min and (iv) a major decrease in the lysine content. In AGE-HSA, glyoxalderived AGEs (CML and G-H1), methylglyoxal-derived AGEs (MG-H1, THP and argpyrimidine) and 3-deoxyglucosone-derived AGEs (3DG-H1, DOLD and pyrraline) were all detected.
The decrease in arginine content in AGE min -HSA, relative to HSA, was $ 6 residues\mol of protein and the AGEs analysed accounted for $ 5 mol\mol of protein of this. The lysine content of AGE min -HSA decreased by $ 1-2 mol\mol of protein and fructosyl-lysine and CML accounted for most of this. In AGE-HSA, the decrease in arginine content was $ 7 arginine residues\ mol of protein and the AGEs analysed accounted for $ 6 mol\mol of protein. The lysine content of AGE-HSA decreased by $ 48 mol\mol of protein but the fructosyl-lysine and lysine-derived AGEs assayed only accounted for 12 mol\mol of protein.
Argpyrimidine and pentosidine in AGE min -HSA and AGE-HSA were also assayed by HPLC with fluorimetric detection without derivatization. Glycation by glucose in AGE min -HSA did not change argpyrimidine content significantly but increased 
Changes in molecular mass of proteins glycated in vitro
The changes in molecular mass of HSA glycated by methylglyoxal and glucose in itro were investigated by matrix-assisted laserdesorption ionization MS (MALDI-MS). Some of these data were presented in a previous study of molecular-mass changes of albumin in uraemia [15] . MALDI-MS of HSA and glycated derivatives prepared in itro gave two peaks with mass\charge ratios identifiable as the double-and mono-charged molecular ions. The mass range of all proteins was relatively small. There was no evidence that a small fraction of HSA derivative was glycated highly and the remainder unglycated. The mass increase of highly glycated proteins, MG-HSA and AGE-HSA, was large ; 3671 and 6780 Da, respectively (Table 4 ).
DISCUSSION
Application of the AQC assay of AGEs to proteins glycated in vitro
The AQC method for assay of AGEs was deployed herein for the analysis of AGEs in HSA modified by methylglyoxal. The long analysis time (220 min) gave rise to some variation between studies in retention times for the long-retained analytes. The relative retention times were reproducible and comparison of these and other controls [17] permitted analyte identification. The advantages of this method over previous estimates of AGEs are (i) a comprehensive survey of contents of non-fluorescent and fluorescent glycation adducts and (ii) estimation of acid-labile glycation adducts. Commercial batches of HSA were found to contain a high and variable amount of G-H1. AQC derivatives of glyoxal hydroimidazolones G-H1 and 2-amino-5-(2-amino-5hydro-4-imidazolon-1-yl)pentanoic acid (G-H2) co-eluted and so the quantification of G-H1 may be unreliable, although we expect similar sensitivities of detection for G-H1 and G-H2. Other AGEs were generally of a very low level although small amounts of 3DG-H1, MG-H1, THP and argpyrimidine could be detected, as well as some fructosyl-lysine.
HSA modified by methylglyoxal in vitro
The modification of HSA minimally with methylglyoxal in MG min -HSA led to the formation mainly of MG-H1, and small amounts of THP and argpyrimidine. MOLD and CEL were below the limits of detection ; although detected in proteins in i o [20, 21] , they are minor products of glycation of proteins by methylglyoxal. When MG min -HSA was prepared with 2-["%C]methylglyoxal, 2.3p0.3 mol of methylglyoxal-derived radio-label\mol of protein were incorporated [12] . This agrees well with the decrease in arginine residues in MG min -HSA found herein. The methylglyoxal residue content of MG min -HSA due to MG-H1, THP and argpyrimidine was 1.41j(2i0.2)j(2i0.13) l 2.07\mol of protein (THP and argpyrimidine being formed from two methylglyoxal residues). The AGEs measured, there- fore, account for all of the modification of arginine residues in MG min -HSA. This was also found for MG min -PR, where total glycation adducts were 4.4 mol of methylglyoxal-derived radio-label\mol of protein ; and use of 2-["%C]methylglyoxal in the preparation of MG min -PR indicated an incorporation of 4.1 methylglyoxal residues\mol of protein [12] . MALDI-MS of MG min -HSA showed a small increase in mass only, relative to HSA. Our previous HPLC gel filtration, SDS\PAGE and isoelectric-focusing studies of MG min -HSA were consistent with this [9] . This minimal glycated HSA derivative is similar in extent of modification to HSA glycated in i o [15] . The time course of formation of methylglyoxal-derived AGEs in MG min -HSA indicated that MG-H1 and THP were the initial adducts formed and that argpyrimidine formation occurred later. This is consistent with the degradation of THP to argpyrimidine [17] . MG-H1 and THP formation was relatively rapid, mostly occurring within 24 h. The reaction of methylglyoxal with HSA to form MG min -HSA was modelled by the incubation of N α -t-Boc-arginine with methylglyoxal. The formation of MG-H1 occurred to a similar extent to that in MG min -HSA, although the initial rate of formation was approximately twice as fast with HSA as with N αt-Boc-arginine. This suggests that there are arginine residues in HSA activated for reaction with methylglyoxal. The formation of THP was increased in the N α -t-Boc-arginine incubation but there was no formation of argpyrimidine ; there may be catalysts for the conversion of THP into argpyrimidine in HSA (trace redox active metal ions, for example). In the N α -t-Boc-arginine incubation, the reaction terminated after forming $ 150 µM equivalents of AGE adducts, accounting for 203 µM methylglyoxal. Most of the N α -t-Boc-arginine remained unmodified. It is unlikely that this was due to the attainment of equilibrium between methylglyoxal and the glycation adducts since the halflife of MG-H1 is $ 12 days [17] . Rather, the incubation had become depleted of methylglyoxal because of (i) MG-H3 adduct formation, which may be similar in amount to MG-H1, (ii) spontaneous degradation of methylglyoxal, estimated to be $ 40 µM over 24 h in this incubation [22] , and (iii) formation of reversible adducts which were lost during sample processing, the glycosylamine N ω -(1-hydroxy-2-oxopropyl)arginine (structure I in Figure 8 ) and the imidazolidine N δ -(4,5-dihydroxy-4-methylimidazolidin-2-yl)ornithine (structure II in Figure 8 ) [23] . Involvement of these processes in the formation of MG min -HSA may explain the termination of the glycation after $ 6 h. Subsequent increased formation of MG-H1 over 3 weeks may arise by isomerism of the unstable MG-H3 to the more stable MG-H1. Consistent with this, the incubation of 100 µM HSA with 100 µM methylglyoxal lead to the formation of only 0.47 methylglyoxal-derived AGEs formed irreversibly\mol of protein [12] .
The formation of MG-H1 and MG-H3 occurred preferentially over that of MG-H2. MG-H1 suffers the least steric hindrance from the δ-ornithyl substituent, and the initial reaction encounter to form MG-H3 involves the most nucleophilic nitrogen atom (N δ ) of the arginyl guanidino group reacting with the most reactive carbonyl group in methylglyoxal (the aldehyde group). MG-H2 was detected in glycated proteins in some instances ; in human lens proteins in i o, for example, where glycation over years achieves thermodynamic equilibrium between all three isomeric forms.
In MG-HSA, there was a further increase in the amount of MG-H1, a marked accumulation of THP and argpyrimidine, and detectable formation of MOLD and CEL. The total methylglyoxal-derived AGEs detected ($ 7 mol of arginine-derived adducts and 2 mol of lysine-derived adducts\mol of protein) accounted for only $ 50 % of the arginine modification and $ 10 % of the lysine modification. Therefore, further methylglyoxal-derived AGEs remain to be discovered in MG-HSA. Alternatively, this protein may be resistant to enzymic hydrolysis giving a poor recovery of amino acids. The molecular mass increase of MG-HSA, relative to HSA, was 3671 Da, which corroborates well with previous estimates by SDS\PAGE [9] . Modification by MG-H1, THP, argpyrimidine, CEL and MOLD combined represents a mass increase of $ 540 Da. The additional mass increment is attributed to the modification of 23 arginine and lysine groups and oxidation of susceptible amino acids. Degradation of 100 mM methylglyoxal forms significant amounts of hydrogen peroxide [22] . MG-HSA is a markedly different protein to MG min -HSA, with a high net negative charge [9] . It is not a good model for proteins glycated in i o, although there may be similar extents of protein glycation in some foodstuffs [24] .
The arginine residues modified in HSA in the formation of MG min -HSA are unknown. Two reactive arginine residues have been identified in HSA : Arg-218 in ligand-binding site I (subdomain 2A) and Arg-410 in site II (subdomain 3A) [25, 26] . They are highly conserved residues and are ' gatekeepers ' of the ligandbinding domains, decreasing the affinity of drugs and other ligands. Arg-410 is also associated with the esterase activity of HSA. Modification of these residues by methylglyoxal is likely to lead to a loss of positive charge on the arginyl moiety and a loss of esterase activity [27] . The concentration of MG-H1 in HSA in i o was below the limit of detection by the AQC chromatographic assay although it has been detected by immunoassay [28] . We estimate that 1 % of HSA is modified by MG-H1 in i o. Hence, methylglyoxal modification of HSA in i o is unlikely to have a marked effect on HSA esterase activity but it may change drug-\ligand-binding affinity of a small proportion of the available binding sites.
HSA modified by glucose in vitro
Preparation of AGE min -HSA led to small increases in 3DG-H1, MG-H1, THP, argpyrimidine and DOLD contents and more substantial increases of CML, fructosyl-lysine and G-H1. A similar increase in fructosyl-lysine content had been seen previously by the fructosamine test [29] . AGE min -HSA had a molecular mass increase of 399 Da, relative to HSA. Fructosyllysine and CML accounted for $ 220 Da of this, and for the decrease of $ 2 residues of lysine\mol of AGE min -HSA. Pentosidine content increased $ 13-fold in the formation of AGE min -HSA but only to a concentration of $ 4 mmol\mol of AGE min -HSA. The arginine-derived AGEs measured herein accounted for most (80 %) of the arginine residues modified, or $ 5 mol\mol of protein. Hence, most of the glycation adducts in AGE min -HSA were identified. Interestingly, when AGE min -HSA was prepared with 1-["%C]glucose only 2 mol of radiolabel\mol were incorporated [12] . Since 1 mol is due to fructosyl-lysine, most of the remaining 6 mol of AGEs in AGE min -HSA must not have contained the 1-["%C] label. This suggests that glucose fragmentation in the early stages of glycation [29] is a major reaction pathway in the glycation of proteins to a minimal extent. AGE analysis of AGE-HSA showed increased contents of the same AGEs found in AGE min -HSA, except for 3DG-H1, and the additional presence of pyrraline. The content of pentosidine in AGE-HSA increased by $ 29-fold but was still only $ 8 mmol\mol of AGE-HSA. The content of fructosyl-lysine was particularly high, $ 8 mol\mol of AGE-HSA, which suggests that AGE-HSA contains a high level of early glycation adduct. CML, G-H1 and argpyrimidine were the major AGEs in AGE-HSA. Most of the decrease in arginine residues in AGE-HSA could be accounted for by the AGEs assayed but $ 75 % of the decrease in lysine residues (36 residues) could not. The mass increase of AGE-HSA with respect to HSA was 6780 Da : fructosyl-lysine residues accounted for $ 1300 Da, and AGEs assayed (MG-H1, THP, argpyrimidine, CEL, DOLD, pyrraline, CML and G-H1) for $ 1600 Da. The remaining mass increase unaccounted for is 3880 Da. This is on 36 modified lysine residues with unidentified modification ; a mean mass increment\ lysine residue of $ 108 Da. Furosine residues (mass increment, 108 Da) and similar structures arising from Schiff 's base and fructosamine degradation are probable structures of the unidentified lysine-derived AGEs. Future work should look for the unidentified lysine-derived AGEs and investigate how these are related to the functional activities of AGE-HSA.
AGEs in HSA glycated in vitro to minimal and high extents by methylglyoxal and glucose
